Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Tracy

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Clinical and Translational Science|December 3, 2014
Social network analysis to assess the impact of the CTSA on biomedical research grant collaborationRadhakrishnan Nagarajan, Charlotte A Peterson, Jane S Lowe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 12, 2006
CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profilesVikas Kumar, Jan L Wahlstrom, Dan A Rock, et al.
Journal of Biomolecular Screening|February 24, 2006
Influence of fluorescent probe size and cytochrome b5 on drug-drug interactions in CYP2C9Matthew A Hummel, Timothy S Tracy, J Matthew Hutzler, et al.
British Journal of Pharmacology|January 22, 2026
A model-based analysis of the CYP2C9 genotype effects on fluconazole inhibition using flurbiprofen, ketoprofen and tolbutamide as probe drugsShen Cheng, Darcy R Flora, Mutaz M Jaber, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profilesTimothy S Tracy, J Matthew Hutzler, Robert L Haining, et al.
Journal of Analytical Toxicology|April 6, 2005
Conversion of methamphetamine to N-methyl-methamphetamine in formalin solutionsPadma S Tirumalai, Diaa M Shakleya, Peter M Gannett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2016
Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and MetabolismChris D Bostick, Katherine M Hickey, Lance A Wollenberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2004
Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in ratsMarion L Williams, Donald E Mager, Heli Parenteau, et al.
Nanotechnology|September 6, 2012
Selective filling of nanowells in nanowell arrays fabricated using polystyrene nanosphere lithography with cytochrome P450 enzymesLance A Wollenberg, John E Jett, Yueting Wu, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
Inhibition of CYP2D6 activity by bupropionMichael Kotlyar, Lisa H Brauer, Timothy S Tracy, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Clinical and Translational Science|December 3, 2014
Social network analysis to assess the impact of the CTSA on biomedical research grant collaborationRadhakrishnan Nagarajan, Charlotte A Peterson, Jane S Lowe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 12, 2006
CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profilesVikas Kumar, Jan L Wahlstrom, Dan A Rock, et al.
Journal of Biomolecular Screening|February 24, 2006
Influence of fluorescent probe size and cytochrome b5 on drug-drug interactions in CYP2C9Matthew A Hummel, Timothy S Tracy, J Matthew Hutzler, et al.
British Journal of Pharmacology|January 22, 2026
A model-based analysis of the CYP2C9 genotype effects on fluconazole inhibition using flurbiprofen, ketoprofen and tolbutamide as probe drugsShen Cheng, Darcy R Flora, Mutaz M Jaber, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profilesTimothy S Tracy, J Matthew Hutzler, Robert L Haining, et al.
Journal of Analytical Toxicology|April 6, 2005
Conversion of methamphetamine to N-methyl-methamphetamine in formalin solutionsPadma S Tirumalai, Diaa M Shakleya, Peter M Gannett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2016
Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and MetabolismChris D Bostick, Katherine M Hickey, Lance A Wollenberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2004
Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in ratsMarion L Williams, Donald E Mager, Heli Parenteau, et al.
Nanotechnology|September 6, 2012
Selective filling of nanowells in nanowell arrays fabricated using polystyrene nanosphere lithography with cytochrome P450 enzymesLance A Wollenberg, John E Jett, Yueting Wu, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
Inhibition of CYP2D6 activity by bupropionMichael Kotlyar, Lisa H Brauer, Timothy S Tracy, et al.
Pageof 8